Quantitative MRI Pharmacokinetic Modeling and MALDI Mass Spectrometry Imaging Biodistribution of a pH Mapping MRI Contrast Agent.

IF 14.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Theranostics Pub Date : 2026-07-05 eCollection Date: 2026-01-01 DOI:10.7150/thno.128499
Zinia Mohanta, Caitlin M Tressler, Sadakatali Gori, Aruna Singh, Julia Stabinska, Shaowei Bo, Sana Karbalaei, Sophie Sall, Assaf Gilad, Hernando Lopez Bertoni, Eric Gale, Kristine Glunde, Michael T McMahon
{"title":"Quantitative MRI Pharmacokinetic Modeling and MALDI Mass Spectrometry Imaging Biodistribution of a pH Mapping MRI Contrast Agent.","authors":"Zinia Mohanta, Caitlin M Tressler, Sadakatali Gori, Aruna Singh, Julia Stabinska, Shaowei Bo, Sana Karbalaei, Sophie Sall, Assaf Gilad, Hernando Lopez Bertoni, Eric Gale, Kristine Glunde, Michael T McMahon","doi":"10.7150/thno.128499","DOIUrl":null,"url":null,"abstract":"<p><p>Chemical exchange saturation transfer (CEST) MRI enables noninvasive mapping of tissue pH, a key biomarker of renal physiology and disease. We report a streamlined, three-step synthesis of diGlu, an anionic imidazole-4,5-dicarboxamide bearing two glutamate substituents, obtained at ≥99.5% purity using SOCl<sub>2</sub>/DMF activation, low-temperature amidation, and mild HCl deprotection-avoiding phenyl-ester intermediates and TFA. The molecule presents two exchangeable protons at 7.7 ppm (imidazole) and 4.5 ppm (amide) whose pH-dependent exchange rates enable a two-offset ratiometric, concentration-independent readout.</p><p><strong>Methods: </strong>C57BL/6J mice received tail-vein injections of 250, 500, or 750 mg kg<sup>-1</sup> I45DC-diGlu for our imaging studies. We established a novel biodistribution and pharmacokinetic analysis methodology employing matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) for biodistribution, CEST imaging and region of interest (ROI)-wise pharmacokinetic (PK) modeling, fitting SE (%) time-courses with log-normal (LN) and Uptake-Plateau-Decay (UPD) models and selecting the model by AICc on the SE time course curves.</p><p><strong>Results: </strong>MALDI-MSI confirmed selective renal localization and unmetabolized probe in urine, with negligible liver or pancreas accumulation. The LN model was best for fitting the CEST MRI data at low doses (unimodal kinetics), whereas UPD captured rise-hold-washout at 750 mg kg<sup>-1</sup>, yielding interpretable biomarkers (SE<sub>max</sub>, TTP, AUC<sub>total</sub>, t<sub>1/2</sub>). Robust renal CEST contrast was observed at ≥ 500 mg kg<sup>-1</sup>. Voxel-wise pH maps reproduced the expected corticomedullary gradient (mean ± SD): cortex 6.86 ± 0.087, outer medulla 6.80 ± 0.073, inner medulla 6.61 ± 0.079, with pH estimates largely dose-independent.</p><p><strong>Conclusions: </strong>Together, the iodine- and metal-free chemistry, dual-offset window, dose-robust pH mapping, and MALDI-validated biodistribution position I45DC-diGlu as a practical scaffold for quantitative renal pH imaging and as a foundation for translational studies for renal pathophysiology.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 14","pages":"7937-7957"},"PeriodicalIF":14.9000,"publicationDate":"2026-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13440279/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.128499","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Chemical exchange saturation transfer (CEST) MRI enables noninvasive mapping of tissue pH, a key biomarker of renal physiology and disease. We report a streamlined, three-step synthesis of diGlu, an anionic imidazole-4,5-dicarboxamide bearing two glutamate substituents, obtained at ≥99.5% purity using SOCl2/DMF activation, low-temperature amidation, and mild HCl deprotection-avoiding phenyl-ester intermediates and TFA. The molecule presents two exchangeable protons at 7.7 ppm (imidazole) and 4.5 ppm (amide) whose pH-dependent exchange rates enable a two-offset ratiometric, concentration-independent readout.

Methods: C57BL/6J mice received tail-vein injections of 250, 500, or 750 mg kg-1 I45DC-diGlu for our imaging studies. We established a novel biodistribution and pharmacokinetic analysis methodology employing matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) for biodistribution, CEST imaging and region of interest (ROI)-wise pharmacokinetic (PK) modeling, fitting SE (%) time-courses with log-normal (LN) and Uptake-Plateau-Decay (UPD) models and selecting the model by AICc on the SE time course curves.

Results: MALDI-MSI confirmed selective renal localization and unmetabolized probe in urine, with negligible liver or pancreas accumulation. The LN model was best for fitting the CEST MRI data at low doses (unimodal kinetics), whereas UPD captured rise-hold-washout at 750 mg kg-1, yielding interpretable biomarkers (SEmax, TTP, AUCtotal, t1/2). Robust renal CEST contrast was observed at ≥ 500 mg kg-1. Voxel-wise pH maps reproduced the expected corticomedullary gradient (mean ± SD): cortex 6.86 ± 0.087, outer medulla 6.80 ± 0.073, inner medulla 6.61 ± 0.079, with pH estimates largely dose-independent.

Conclusions: Together, the iodine- and metal-free chemistry, dual-offset window, dose-robust pH mapping, and MALDI-validated biodistribution position I45DC-diGlu as a practical scaffold for quantitative renal pH imaging and as a foundation for translational studies for renal pathophysiology.

定量MRI药代动力学建模和MALDI质谱成像pH定位MRI造影剂的生物分布。
化学交换饱和转移(CEST) MRI能够无创地绘制组织pH值,这是肾脏生理和疾病的关键生物标志物。我们报道了一种具有两个谷氨酸取代基的阴离子咪唑-4,5-二甲酰胺diGlu的流线型三步合成方法,该方法使用SOCl2/DMF活化,低温酰胺化,温和的避免HCl脱保护的苯基酯中间体和TFA,纯度≥99.5%。该分子在7.7 ppm(咪唑)和4.5 ppm(酰胺)的浓度下呈现两个可交换质子,其ph依赖的交换速率使双偏移比例,浓度无关的读数成为可能。方法:C57BL/6J小鼠尾静脉注射250、500或750 mg kg-1 I45DC-diGlu进行影像学研究。我们建立了一种新的生物分布和药代动力学分析方法,采用基质辅助激光解吸/电离(MALDI)质谱成像(MSI)进行生物分布,CEST成像和感兴趣区域(ROI)药物动力学(PK)建模,将SE(%)时间过程与对数正态(LN)和摄取-高原衰减(UPD)模型拟合,并通过AICc在SE时间过程曲线上选择模型。结果:MALDI-MSI证实选择性肾定位和尿中未代谢探针,肝脏或胰腺积聚可忽略不计。LN模型在低剂量(单峰动力学)下最适合拟合CEST MRI数据,而UPD在750 mg kg-1时捕获上升-保持冲刷,产生可解释的生物标志物(SEmax, TTP, AUCtotal, t1/2)。≥500 mg kg-1时,肾脏CEST对比明显增强。体素pH图再现了预期的皮质-髓质梯度(平均±SD):皮层6.86±0.087,外髓质6.80±0.073,内髓质6.61±0.079,pH值估计在很大程度上与剂量无关。结论:I45DC-diGlu具有不含碘和金属的化学性质、双偏置窗口、剂量稳健的pH定位以及maldi验证的生物分布特性,可作为定量肾脏pH成像的实用支架,并为肾脏病理生理学的转化研究奠定基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Theranostics
Theranostics MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
25.40
自引率
1.60%
发文量
433
审稿时长
1 months
期刊介绍: Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书